Topical Loperamide-Encapsulated Liposomal Gel Increases the Severity of Inflammation and Accelerates Disease Progression in the Adjuvant-Induced Model of Experimental Rheumatoid Arthritis
This study evaluates the prophylactic effect of the peripherally-selective mu-opioid receptor agonist, loperamide, administered topically in a liposomal gel formulation on pain, inflammation, and disease progression in the adjuvant-induced model of experimental rheumatoid arthritis in female Lewis r...
Saved in:
Main Authors: | Susan Hua (Author), Thilani H. Dias (Author), Debbie-Gai Pepperall (Author), Yuan Yang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liposomal Nanosystems in Rheumatoid Arthritis
by: Margarida Ferreira-Silva, et al.
Published: (2021) -
Simvastatin-Encapsulated Topical Liposomal Gel for Augmented Wound Healing: Optimization Using the Box-Behnken Model, Evaluations, and In Vivo Studies
by: Mohamed Rahamathulla, et al.
Published: (2024) -
Pharmaceutical development of etodolac transfersomal gel for topical drug delivery system in rheumatoid arthritis
by: Ashwini Bachhav, et al.
Published: (2024) -
Loperamide abuse and cardiotoxicity
by: Nichole A. Smith, et al.
Published: (2017) -
Melittin promotes dexamethasone in the treatment of adjuvant rheumatoid arthritis in rats
by: Linfu Yang, et al.
Published: (2024)